Dr Xavier Rajesh Packianathan, MD | |
633 Gov Carlos Camacho Rd, Suite 210, Tamuning, GU 96913 | |
(671) 649-1001 | |
Not Available |
Full Name | Dr Xavier Rajesh Packianathan |
---|---|
Gender | Male |
Speciality | Interventional Radiology |
Experience | 14 Years |
Location | 633 Gov Carlos Camacho Rd, Tamuning, Guam |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1669692059 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
St Louis University Hospital | Saint louis, MO | Hospital |
Ssm Health St Mary's Hospital - St Louis | Richmond heights, MO | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Ssm Health Care Group | 0143608372 | 678 |
News Archive
For the first time, Tübingen neuroscientists were able to differentiate between active and inactive cells in the brain morphologically, i.e. based on the cells' structure.
Boehringer Ingelheim and Eli Lilly and Company today presented the full results of the long-term cardiovascular outcome trial, CARMELINA®, which studied the impact of Trajenta® (linagliptin) on cardiovascular and kidney safety in adults with type 2 diabetes at high risk for heart and/or kidney disease.
University of California, Berkeley, neuroscientists have discovered a genetic trigger that makes the nose renew its smell sensors, providing hope for new therapies for people who have lost their sense of smell due to trauma or old age.
"As we mark World [Tuberculosis (TB)] Day on Sunday March 24, there can be no denying that TB, fueled by drug resistance, continues to pose a serious global health threat - one that must be urgently addressed," John Lechleiter, chair, president and CEO of Eli Lilly and Company and chair of the board of PhRMA, writes in a Forbes opinion piece, adding, "With resistance spreading, we need a renewed global commitment that combines public and private efforts to defeat TB."
› Verified 5 days ago
Entity Name | Ssm Health Care St Louis |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1275586174 PECOS PAC ID: 7810800737 Enrollment ID: O20031118000393 |
News Archive
For the first time, Tübingen neuroscientists were able to differentiate between active and inactive cells in the brain morphologically, i.e. based on the cells' structure.
Boehringer Ingelheim and Eli Lilly and Company today presented the full results of the long-term cardiovascular outcome trial, CARMELINA®, which studied the impact of Trajenta® (linagliptin) on cardiovascular and kidney safety in adults with type 2 diabetes at high risk for heart and/or kidney disease.
University of California, Berkeley, neuroscientists have discovered a genetic trigger that makes the nose renew its smell sensors, providing hope for new therapies for people who have lost their sense of smell due to trauma or old age.
"As we mark World [Tuberculosis (TB)] Day on Sunday March 24, there can be no denying that TB, fueled by drug resistance, continues to pose a serious global health threat - one that must be urgently addressed," John Lechleiter, chair, president and CEO of Eli Lilly and Company and chair of the board of PhRMA, writes in a Forbes opinion piece, adding, "With resistance spreading, we need a renewed global commitment that combines public and private efforts to defeat TB."
› Verified 5 days ago
Entity Name | Ssm Cardinal Glennon Children's Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1174577670 PECOS PAC ID: 7012828163 Enrollment ID: O20031231000604 |
News Archive
For the first time, Tübingen neuroscientists were able to differentiate between active and inactive cells in the brain morphologically, i.e. based on the cells' structure.
Boehringer Ingelheim and Eli Lilly and Company today presented the full results of the long-term cardiovascular outcome trial, CARMELINA®, which studied the impact of Trajenta® (linagliptin) on cardiovascular and kidney safety in adults with type 2 diabetes at high risk for heart and/or kidney disease.
University of California, Berkeley, neuroscientists have discovered a genetic trigger that makes the nose renew its smell sensors, providing hope for new therapies for people who have lost their sense of smell due to trauma or old age.
"As we mark World [Tuberculosis (TB)] Day on Sunday March 24, there can be no denying that TB, fueled by drug resistance, continues to pose a serious global health threat - one that must be urgently addressed," John Lechleiter, chair, president and CEO of Eli Lilly and Company and chair of the board of PhRMA, writes in a Forbes opinion piece, adding, "With resistance spreading, we need a renewed global commitment that combines public and private efforts to defeat TB."
› Verified 5 days ago
Entity Name | Ssm Health Care Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1306589544 PECOS PAC ID: 0143608372 Enrollment ID: O20220531002655 |
News Archive
For the first time, Tübingen neuroscientists were able to differentiate between active and inactive cells in the brain morphologically, i.e. based on the cells' structure.
Boehringer Ingelheim and Eli Lilly and Company today presented the full results of the long-term cardiovascular outcome trial, CARMELINA®, which studied the impact of Trajenta® (linagliptin) on cardiovascular and kidney safety in adults with type 2 diabetes at high risk for heart and/or kidney disease.
University of California, Berkeley, neuroscientists have discovered a genetic trigger that makes the nose renew its smell sensors, providing hope for new therapies for people who have lost their sense of smell due to trauma or old age.
"As we mark World [Tuberculosis (TB)] Day on Sunday March 24, there can be no denying that TB, fueled by drug resistance, continues to pose a serious global health threat - one that must be urgently addressed," John Lechleiter, chair, president and CEO of Eli Lilly and Company and chair of the board of PhRMA, writes in a Forbes opinion piece, adding, "With resistance spreading, we need a renewed global commitment that combines public and private efforts to defeat TB."
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Xavier Rajesh Packianathan, MD 116 Redondo De Francisco St, Tamuning, GU 96913-3718 Ph: (671) 483-9226 | Dr Xavier Rajesh Packianathan, MD 633 Gov Carlos Camacho Rd, Suite 210, Tamuning, GU 96913 Ph: (671) 649-1001 |
News Archive
For the first time, Tübingen neuroscientists were able to differentiate between active and inactive cells in the brain morphologically, i.e. based on the cells' structure.
Boehringer Ingelheim and Eli Lilly and Company today presented the full results of the long-term cardiovascular outcome trial, CARMELINA®, which studied the impact of Trajenta® (linagliptin) on cardiovascular and kidney safety in adults with type 2 diabetes at high risk for heart and/or kidney disease.
University of California, Berkeley, neuroscientists have discovered a genetic trigger that makes the nose renew its smell sensors, providing hope for new therapies for people who have lost their sense of smell due to trauma or old age.
"As we mark World [Tuberculosis (TB)] Day on Sunday March 24, there can be no denying that TB, fueled by drug resistance, continues to pose a serious global health threat - one that must be urgently addressed," John Lechleiter, chair, president and CEO of Eli Lilly and Company and chair of the board of PhRMA, writes in a Forbes opinion piece, adding, "With resistance spreading, we need a renewed global commitment that combines public and private efforts to defeat TB."
› Verified 5 days ago
Eric William Spak, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 301 Frank H Cushing Way # 3a, Tamuning, GU 96913 Phone: 671-687-6544 | |
Dr. Laura Taylor, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 633 Carols Camacho Rd, Suite 210, Tamuning, GU 96913 Phone: 671-646-1001 | |
Eythor Bjorgvinsson, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 633 Gov. Carlos Camacho Rd, Ste 210 Guam Medical Plaza, Tamuning, GU 96913 Phone: 671-649-1001 Fax: 671-649-1002 | |
Dr. Peachy Mae Tadifa Piana-pacheco, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 633 Gov Carlos Camacho Road Suite 210, Tamuning, GU 96913 Phone: 671-649-1001 Fax: 671-649-1002 | |
Nathaniel Benjamin Berg, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 633 Governor Carlos Camacho Road, Suite 210, Tamuning, GU 96913 Phone: 671-649-1001 Fax: 671-649-1002 | |
Jeffery D. Shay, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: Guam Medical Plaza, Ste. 210, 633 Gov. Camacho Rd, Tamuning, GU 96913 Phone: 671-649-1001 Fax: 671-649-1002 |